Physician profile
Benjamin P Schaefer
NPI 1356444335
$1,130.74
in general payments reported to CMS, 2019-2025
15 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.31 · 2023: $352 · 2024: $620 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $422.44 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $242.01 | 2023-2024 | Airsupra, Farxiga, Breztri |
| Otsuka America Pharmaceutical, INC. | $79.49 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $59.32 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $58.25 | 2023-2024 | Jardiance, Zepbound |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $50.25 | 2023-2024 | Caplyta |
| Abbvie INC. | $45.83 | 2023-2024 | |
| Glaxosmithkline, LLC. | $32.64 | 2023 | Trelegy Ellipta, Shingrix |
| Neurocrine Biosciences, INC. | $24.52 | 2023 | Ingrezza |
| Axsome Therapeutics, INC. | $24.41 | 2023 | Auvelity |
| Mylan Specialty L.P. | $19.78 | 2024 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $19.31 | 2022 | |
| Lundbeck LLC | $17.96 | 2024 | Rexulti |
| Novartis Pharmaceuticals Corporation | $17.57 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.96 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.